Opioid-Free Anesthetic Alternative Agents - Intraoperative    body {font-family: 'Open Sans', sans-serif;}

### Opioid-Free Anesthetic Alternative Agents - Intraoperative

**Intraoperative considerations for combined multimodal interventions:  
Ketamine** **and MgSO4:** N-methyl-D-Aspartate receptor antagonists  
**Systemic Lidocaine:** (Sodium channel blocker)**Clonidine** and **Dexmedetomidine:** (Alpha-2 adrenergic agonists)  
IV Acetaminophen (Ofirmev) & NSAIDs (Ketorolac)**Ketamine:** (N-methyl-D-Aspartate receptor antagonist)  
**Intraoperative Doses:  
Induction:** 1 - 2 mg/kg IV  
**Intense analgesia (subanesthetic):** 0.2 - 0.5 mg/kg IV  
**ERAS procedures:** 5 - 10 mg boluses up to a total of 0.5 mg/kg  
**Continuous infusion:** 0.2 mg/kg/hour (rare)  
\- Administration of subanesthetic doses perioperatively decreased opioid requirements within the initial 24 hours post-op\- Low-dose ketamine can reduce postoperative hydromorphone requirements for opioid-tolerant patients  
\- Effective anti-hyperalgesic adjuvant due to opioid-sparing effects  
  
**Systemic Lidocaine:**  
**Intraoperative Doses:  
Continuous infusion:** 1-2 mg/kg/hr (most common infusion dose)  
\- Possibly more effective than systemic ketamine in improving the quality of acute pain management _without causing_ significant _complications_ in OUD patients  
\- Perioperative use reduced opioid consumption and postoperative pain with minimal side effects; resulted in earlier gastrointestinal function after abdominal surgeries in the general population.  
  
**Clonidine:** Rarely administered intraoperatively  
**Intraoperative dose:** 0.5 mcg/kg IV over 0-20 minutes  
Beneficial in reducing withdrawal symptoms and postoperative pain due to sedative, analgesic and anxiolytic properties.  
Rarely administered intraoperatively  
  
**Dexmedetomidine** **(Precedex):** Most popular Alpha-2 adrenergic agonist administered perioperatively.  
**Intraoperative doses:** 0.1 - 0.5 mcg/kg/hour after induction or  
Intermittent boluses less than a total of 0.5 mcg/kg.  
\- Minimally studied; several individual case studies indicating improved postoperative pain in opioid-tolerant and OUD populations.  
**Magnesium Sulfate (MgSO4)** (N-methyl-D-Aspartate receptor antagonist):  
\- Attenuates surgical stress response\- Prevents the occurrence of opioid-induced hyperalgesia (OIH)  
\- Consider it for its opioid-sparing effects on the general population  
  
**IV Acetaminophen (Ofirmev) & NSAIDs (Ketorolac):  
**Consider it for its opioid-sparing effects on the general population  
**Ofirmiv Dose:** 1 gram IV**Ketolorac:** 15 mg IV  
**Combined Multimodal Interventions:  
**\- Literature suggests pain management for OUD patients is most successful when utilizing a variety of multimodal interventions.  
**Studied successful combinations:  
**\- Regional anesthesia, ketamine infusion, opioid rotation  
\- Regional anesthesia plus three or more multimodal adjuvants (e.g., acetaminophen, gabapentin, ketorolac, or ketamine)  
\- Preoperative acetaminophen, gabapentin, and celecoxib; intraoperative ketorolac, lidocaine, MgSO4 , limited opioids, TAP block (if applicable); postoperative acetaminophen, gabapentin, celecoxib, and PRN opioids  
\- MgSO4 & Ketamine  
  

Education for Perioperative Anesthetic Management of Opioid Use Disorder  
By Rachel Pelletier, Keri Mulhern and Elizabeth Lucaj  
Florida Gulf Coast University  
  
Multimodal Analgesia: The Foundation of a Successful Perioperative Experience  
Anesthesiology News Special edition 2019  
Accesse3d 02/2023  
Eric S. Schwenk, MD and Edward R. Mariano, MD, MAS  
https://tinyurl.com/fcrm2p6y  
  
13 Aroke, E. N., McMullan, S. P., Woodfin, K. O., Richey, R., Doss, J., & Wilbanks, B. A. (2020).  
A practical approach to acute postoperative pain management in chronic pain patients.  
_Journal of PeriAnesthesia Nursing_ , _35_ (6), 564–573.  
https://doi.org/10.1016/j.jopan.2020.03.002  
  
Boenigk, K., Echevarria, G. C., Nisimov, E., von Bergen Granell, A. E., Cuff, G. E., Wang, J., & Atchabahian, A. (2019).  
Low-dose ketamine infusion reduces postoperative hydromorphone requirements in opioid-tolerant patients following spinal fusion: A randomised controlled trial.  
_European Journal of Anaesthesiology_ , _36_ (1), 8–15.  
https://doi.org/10.1097/EJA.0000000000000877  
  
19 Meyer-Frießem, C. H., Lipke, E., Weibel, S., Kranke, P., Reichl, S., Pogatzki-Zahn, E. M., Zahn, P. K., & Schnabel, A. (2022).  
Perioperative ketamine for postoperative pain management in patients with preoperative opioid intake: A systematic review and meta-analysis.  
_Journal of Clinical Anesthesia_ , _78_ , 1–11.  
https://doi.org/10.1016/j.jclinane.2022.110652  
  
23 Wu, J., Ku, S. C., & Ko, A. L. (2019).  
Use of dexmedetomidine for postoperative pain management following spine fusion surgery in a highly opioid-tolerant patient.  
_Journal of Pain & Palliative Care Pharmacotherapy_ , _33_ (1–2), 49–53.  
https://doi.org/10.1080/15360288.2019.1651439  
  
24 Patch III, R. K., Eldrige, J. S., Moeschler, S. M., & Pingree, M. J. (2017).  
Dexmedetomidine as part of a multimodal analgesic treatment regimen for opioid induced hyperalgesia in a patient with significant opioid tolerance.  
_Case Reports in Anesthesiology_ , _2017_ , 1–5.  
https://doi.org/10.1155/2017/9876306  
  
25 Silvaggio, M. P., Toman, M. K., & Peters, B. (2020).  
Epidural dexmedetomidine infusion in a patient with chronic opioid use and intractable pain following abdominoperineal resection.  
_Oxford Medical Case Reports_ , _2020_ (4–5), 1–4.  
https://doi.org/10.1093/omcr/omaa021  
  
Heldreich, C., Meyer, I., Dube, E., Hu, R., Howard, W., Holmes, N., Maroon, N., Weinberg, L., & Tan, C. O. (2022).  
Peri-OPerative Pain Management, Education & De-escalation (POPPMED), a novel anaesthesiologist-led program, significantly reduces acute and long-term postoperative opioid requirements: A retrospective cohort study.  
_Pain Reports_ , _7_ (5), 1–9.  
https://doi.org/10.1097/PR9.0000000000001028  
  
Truong, A., Mujukian, A., Fleshner, P., & Zaghiyan, K. (2019). No pain, more gain:  
Reduced postoperative opioid consumption with a standardized opioid-sparing multimodal analgesia protocol in opioid-tolerant patients undergoing colorectal surgery.  
_The American Surgeon_ , _85_ (10), 1155–1158.  
https://tinyurl.com/yc7fmypr